arrow
M

Mauro Loi

Azienda Ospedaliero-Universitaria Careggi
H指数:29
被引数:2,549

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Stereotactic body radiotherapy in patients with bone oligometastases from breast cancer – results from a European multicenter cohort study

乳腺癌骨寡转移患者中的立体定向体部放射治疗——来自一项欧洲多中心队列研究的结果

2026-03-030
OAAI
Oncological outcomes after tailored PSMA-PET-guided treatment in biochemical relapse after prostatectomy (PSICHE Trial—NCT 05022914)

前列腺切除术后生化复发患者经个体化PSMA-PET指导治疗的肿瘤学结局(PSICHE试验—NCT 05022914)

2025-10-130
PRE
Re-irradiation in patients affected by prostate cancer and relapsing after previous definitive or postoperative radiotherapy. An international registry based study on behalf of Italian association of radiotherapy and clinical oncology (AIRO). (RE-START)

对受前列腺癌影响并在接受前期根治性或术后放射治疗后复发的患者进行再放射治疗。一项由意大利放射治疗与临床肿瘤学协会(AIRO)代表开展的国际注册研究(RE-START)。

2025-09-130
PRE
Integrating Radiomics and Artificial Intelligence (AI) in Stereotactic Body Radiotherapy (SBRT)/Stereotactic Radiosurgery (SRS): Predictive Tools for Tailored Cancer Care

将放射组学与人工智能(AI)整合应用于立体定向体部放射治疗(SBRT)/立体定向放射外科(SRS):用于定制化癌症护理的预测工具

2025-09-040
OAAI
Oligometastatic Mesothelioma Treated with Ablative Radiotherapy (OMAR): A Multicenter Study

寡转移性间皮瘤经消融放疗治疗(OMAR):一项多中心研究

2025-08-270
OA
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719)
2025-02-190
PRE
Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort
2023-09-201
PRE
Pattern of recurrence after stereotactic body radiotherapy for para-aortic oligo-recurrent prostate cancer, a multicentric analysis
2023-08-193
PRE
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results

PSMA指导前列腺切除术后生化复发的早期生化结果-PSICHE试验 (NCT05022914): 初步结果

2023-04-036
OAAI
The role of brain radiotherapy for EGFR- and ALK-positive non-small-cell lung cancer with brain metastases: a review
2023-02-1414
OAAI